DCGI Apporval For Corbevax – Covid-19 Vaccine Corbevax is delivered to the body through the muscles and requires two doses of this vaccine in 28 days. The vaccine is stored at temperatures of 2 to 8 ° C.
DCGI Apporves Emergency Use Of Corbevax For Children
India has now got another new weapon for its ongoing war against Corona. In order to expedite the vaccination of children, the Drugs Controller General of India (DCGI) has given the final approval for the Corona Vaccine to the Corona Vaccine of Biological E Limited. In the country, this vaccine ( Covid-19 Vaccine ) is given to children aged 12 to 18 years.
Drugs Controller General of India (DCGI) grants final approval to Biological E's #COVID19 vaccine Corbevax, for children between 12-18 years of age. pic.twitter.com/ad2xftvmzB
— ANI (@ANI) February 21, 2022
vaccine manufacturer Biological E Ltd for children aged 12 to 18 says DCGI has approved a local vaccine for emergency use of children between the ages of 12 and 18. It is noteworthy here that the Drugs Controller General of India has already approved the Emergency Use of Carbavax for Adults. Corbevax is India’s first locally developed RBD protein sub-component vaccine against corona.
Take two doses in 28 days
Just last week, the Central Drug Regulatory Subject Expert Panel (SEC) recommended the approval of the Biologic-E Corona Vaccine Carbeaux for emergency use for children aged 12 to 18 with certain conditions. It was then sent to the Drug Controller General of India (DCGI) for final approval.